Oğüt M S, Bozkurt N, Ozek E, Birgen H, Kazokoğlú H, Oğüt M
Department of Ophthalmology, Marmara University Faculty of Medicine, Haydarpasa Numune Hospital, Istanbul, Turkey.
Eur J Ophthalmol. 1996 Apr-Jun;6(2):192-6. doi: 10.1177/112067219600600218.
The pupils of neonates and premature infants often need to be dilated for retinal examination. The drops used for this purpose have some known side effects. This study investigated the effects and side effects of these drops. In this prospective randomized study, 80 healthy neonates were randomly assigned to eight groups. In Group A 1% cyclopentolate was used; in Group B 1% tropicamide; in Group C 2.5% phenylephrine; in Group D 1% cyclopentolate and 1% tropicamide; in Group E 2.5% phenylephrine and 1% tropicamide; in Group F 0.5% cyclopentolate, 0.5% tropicamide and 2.5% phenylephrine; in Group G 1% cyclopentolate and 2.5% phenylephrine and in Group H 0.9% NaCl. Heart rate, systolic and diastolic blood pressures were recorded before, and 5, 10, 15, 30, 45, 60 minutes after instillation of the drops. Pupillary size was measured at baseline, 30 and 60 minutes. To stimulate the conditions of indirect ophthalmoscopic examination, the pupil sizes were measured under the intense beam of a halogen light. The results were analyzed statistically. Maximum side effects were seen in group C; the safest was group B and maximum mydriasis was achieved in group F.
新生儿和早产儿的瞳孔通常需要散瞳以进行视网膜检查。用于此目的的滴眼液有一些已知的副作用。本研究调查了这些滴眼液的效果和副作用。在这项前瞻性随机研究中,80名健康新生儿被随机分为八组。A组使用1%环喷托酯;B组使用1%托吡卡胺;C组使用2.5%去氧肾上腺素;D组使用1%环喷托酯和1%托吡卡胺;E组使用2.5%去氧肾上腺素和1%托吡卡胺;F组使用0.5%环喷托酯、0.5%托吡卡胺和2.5%去氧肾上腺素;G组使用1%环喷托酯和2.5%去氧肾上腺素;H组使用0.9%氯化钠。在滴入滴眼液前以及滴入后5、10、15、30、45、60分钟记录心率、收缩压和舒张压。在基线、30分钟和60分钟时测量瞳孔大小。为模拟间接检眼镜检查的条件,在卤素灯强光下测量瞳孔大小。对结果进行统计学分析。C组出现的副作用最大;最安全的是B组,F组实现了最大程度的散瞳。